81 related articles for article (PubMed ID: 25044938)
1. Benzocyclobutane, benzocycloheptane and heptene derivatives as melatonin agonists and antagonists.
Tsotinis A; Afroudakis PA; Garratt PJ; Bocianowska-Zbrog A; Sugden D
ChemMedChem; 2014 Oct; 9(10):2238-43. PubMed ID: 25044938
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and melatoninergic potency of new N-acyl 8,9-dihydro-4-methoxy-7H-2-benzo[de]quinolinalkanamines.
Tsotinis A; Eleutheriades A; Hough KA; Davidson K; Sugden D
Bioorg Chem; 2007 Apr; 35(2):189-204. PubMed ID: 17223160
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the structure-activity relationships of melatonin receptor agonists and antagonists: lengthening the N-acyl side-chain has differing effects on potency on Xenopus melanophores.
Teh MT; Sugden D
Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):522-8. PubMed ID: 9840420
[TBL] [Abstract][Full Text] [Related]
4. Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.
Faust R; Garratt PJ; Jones R; Yeh LK; Tsotinis A; Panoussopoulou M; Calogeropoulou T; Teh MT; Sugden D
J Med Chem; 2000 Mar; 43(6):1050-61. PubMed ID: 10737738
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors.
Mathé-Allainmat M; Gaudy F; Sicsic S; Dangy-Caye AL; Shen S; Brémont B; Benatalah Z; Langlois M; Renard P; Delagrange P
J Med Chem; 1996 Aug; 39(16):3089-95. PubMed ID: 8759629
[TBL] [Abstract][Full Text] [Related]
6. Mapping the melatonin receptor. 5. Melatonin agonists and antagonists derived from tetrahydrocyclopent[b]indoles, tetrahydrocarbazoles and hexahydrocyclohept[b]indoles.
Davies DJ; Garratt PJ; Tocher DA; Vonhoff S; Davies J; Teh MT; Sugden D
J Med Chem; 1998 Feb; 41(4):451-67. PubMed ID: 9484496
[TBL] [Abstract][Full Text] [Related]
7. Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.
Lucini V; Pannacci M; Scaglione F; Fraschini F; Rivara S; Mor M; Bordi F; Plazzi PV; Spadoni G; Bedini A; Piersanti G; Diamantini G; Tarzia G
J Med Chem; 2004 Aug; 47(17):4202-12. PubMed ID: 15293992
[TBL] [Abstract][Full Text] [Related]
8. Mapping the Melatonin Receptor. 8. Selective MT2 Agonists Derived from 5,6-Dihydroindolo[2,1-a]isoquinolines and Related Systems.
Tsotinis A; Afroudakis PA; Papanastasiou IP; Sakellaropoulou A; Boniakou M; Komiotis D; Garratt PJ; Delagrange P; Bocianowska-Zbrog A; Sugden D
ChemMedChem; 2022 Jun; 17(12):e202200129. PubMed ID: 35478275
[TBL] [Abstract][Full Text] [Related]
9. New melatonin (MT1/MT2) ligands: design and synthesis of (8,9-dihydro-7H-furo[3,2-f]chromen-1-yl) derivatives.
Landagaray E; Ettaoussi M; Leclerc V; Traoré B; Perez V; Nosjean O; Boutin JA; Caignard DH; Delagrange P; Berthelot P; Yous S
Bioorg Med Chem; 2014 Feb; 22(3):986-96. PubMed ID: 24417958
[TBL] [Abstract][Full Text] [Related]
10. Bicyclic melatonin receptor agonists containing a ring-junction nitrogen: Synthesis, biological evaluation, and molecular modeling of the putative bioactive conformation.
Elsner J; Boeckler F; Davidson K; Sugden D; Gmeiner P
Bioorg Med Chem; 2006 Mar; 14(6):1949-58. PubMed ID: 16290939
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of 1-(2-alkanamidoethyl)-6-methoxy-7-azaindole derivatives as potent melatonin agonists.
Jeanty M; Suzenet F; Delagrange P; Nosjean O; Boutin JA; Caignard DH; Guillaumet G
Bioorg Med Chem Lett; 2011 Apr; 21(8):2316-9. PubMed ID: 21420861
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity.
Spadoni G; Diamantini G; Bedini A; Tarzia G; Vacondio F; Silva C; Rivara M; Mor M; Plazzi PV; Zusso M; Franceschini D; Giusti P
J Pineal Res; 2006 Apr; 40(3):259-69. PubMed ID: 16499563
[TBL] [Abstract][Full Text] [Related]
13. Mapping the melatonin receptor. 7. Subtype selective ligands based on beta-substituted N-acyl-5-methoxytryptamines and beta-substituted N-acyl-5-methoxy-1-methyltryptamines.
Tsotinis A; Vlachou M; Papahatjis DP; Calogeropoulou T; Nikas SP; Garratt PJ; Piccio V; Vonhoff S; Davidson K; Teh MT; Sugden D
J Med Chem; 2006 Jun; 49(12):3509-19. PubMed ID: 16759094
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of new tricyclic melatoninergic ligands.
Tsotinis A; Panoussopoulou M; Sivananthan S; Sugden D
Farmaco; 2001 Sep; 56(9):725-9. PubMed ID: 11680819
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological evaluation of pentacyclic 6a,7-dihydrodiindole and 2,3-dihydrodiindole derivatives as novel melatoninergic ligands.
Attia MI; Witt-Enderby PA; Julius J
Bioorg Med Chem; 2008 Aug; 16(16):7654-61. PubMed ID: 18657980
[TBL] [Abstract][Full Text] [Related]
16. 1-(2-Alkanamidoethyl)-6-methoxyindole derivatives: a new class of potent indole melatonin analogues.
Tarzia G; Diamantini G; Di Giacomo B; Spadoni G; Esposti D; Nonno R; Lucini V; Pannacci M; Fraschini F; Stankov BM
J Med Chem; 1997 Jun; 40(13):2003-10. PubMed ID: 9207941
[TBL] [Abstract][Full Text] [Related]
17. High-throughput screening assay for new ligands at human melatonin receptors.
Yan JH; Su HR; Boutin JA; Renard MP; Wang MW
Acta Pharmacol Sin; 2008 Dec; 29(12):1515-21. PubMed ID: 19026172
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of new N-OMe fluoro-indole melatoninergics.
Tsotinis A; Gourgourinis J; Eleutheriades A; Davidson K; Sugden D
Med Chem; 2007 Nov; 3(6):561-71. PubMed ID: 18045206
[TBL] [Abstract][Full Text] [Related]
19. Aggregation of pigment granules in single cultured Xenopus laevis melanophores by melatonin analogues.
Sugden D
Br J Pharmacol; 1991 Dec; 104(4):922-7. PubMed ID: 1667293
[TBL] [Abstract][Full Text] [Related]
20. Mapping the melatonin receptor. 3. Design and synthesis of melatonin agonists and antagonists derived from 2-phenyltryptamines.
Garratt PJ; Jones R; Tocher DA; Sugden D
J Med Chem; 1995 Mar; 38(7):1132-9. PubMed ID: 7707316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
